🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
This is a Phase Ib study in healthy adults (18-70 years) to evaluate the sa...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-08
Trial ID
NCT01676402
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this research study is to evaluate the immune response to th...
Status
Completed
Location
Univ. of Alabama Birmingham NICHD CRS (5096)
Start Date
2009-10
Trial ID
NCT01484522
This study will evaluate the safety and immunogenicity in healthy children ...
Status
Completed
Location
Centro de Atención e Investigación Medica - CAIMED
Start Date
2010-09
Trial ID
NCT01209780
Treatments Being Tested
A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Status
Completed
Location
US135
Start Date
2019-10-14
Trial ID
NCT04120194
Treatments Being Tested
The primary objectives of this study are to evaluate the humoral immunogeni...
Status
Completed
Location
CEI -Centro de Estudios Infectológicos
Start Date
2022-06-06
Trial ID
NCT05415462
Treatments Being Tested
The purpose of this study is to learn about how the flu and COVID vaccines ...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2025-02-10
Trial ID
NCT06821061
Evaluate safety and immunogenicity of three influenza vaccines in adults 18...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01992094
This study compares the immunogenity and safety of quadrivalent inactivated...
Status
Unknown
Location
Hospital Puerto Montt
Start Date
2022-07-14
Trial ID
NCT05494047
Treatments Being Tested